What are the respiratory adverse effects associated with dexamethasone, listed from most common to least common?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dexamethasone-Induced Respiratory Side Effects

Based on FDA labeling and clinical evidence, dexamethasone does not directly cause common respiratory adverse effects; rather, it increases susceptibility to respiratory infections as its primary respiratory concern. 1

Respiratory Adverse Effects (Most to Least Common)

1. Respiratory Infections (Most Common)

  • Pneumonia and other lung infections are the most frequently documented respiratory complication 1, 2
  • Occurs due to immunosuppression from corticosteroid therapy
  • In ARDS trials, new infections including pneumonia occurred in approximately 24% of dexamethasone-treated patients 2
  • Patients on immunosuppressive doses are more susceptible to infections than healthy individuals 1

2. Fungal Respiratory Infections

  • Dexamethasone may exacerbate systemic fungal infections 1
  • Secondary ocular infections due to fungi or viruses can occur with prolonged use, though this is less common than bacterial pneumonia 1

3. Reactivation of Latent Infections

  • Can activate latent amebiasis 1
  • May mask signs of infection, making new infections harder to detect 1

4. Barotrauma (Least Common)

  • Occurred in approximately 10% of dexamethasone-treated ARDS patients versus 7% in controls 2
  • This is an indirect effect related to mechanical ventilation rather than a direct drug effect

Critical Clinical Context

Important distinction: The evidence shows dexamethasone actually improves respiratory outcomes in specific conditions:

  • Reduces mortality and increases ventilator-free days in moderate-to-severe ARDS 2
  • Decreases duration of mechanical ventilation 3, 2
  • Alleviates acute respiratory distress syndrome 4

Common pitfall: Clinicians may confuse therapeutic respiratory benefits with adverse effects. The primary respiratory concern is increased infection susceptibility, not direct respiratory toxicity.

Monitoring Recommendations

  • Watch for signs of new respiratory infections, particularly pneumonia
  • Rule out latent infections (especially amebiasis in patients with tropical exposure) before initiating therapy 1
  • Recognize that corticosteroids may mask infection signs and decrease ability to localize infections 1
  • Be aware that expected antibody responses to vaccines may not occur in patients on immunosuppressive doses 1

Note: Other common dexamethasone adverse effects (hyperglycemia in 70-76% of ICU patients, gastritis, cardiovascular issues) are non-respiratory and far more frequent than respiratory complications 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.